Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo

Mandy L. Ballinger, Narin Osman, Kazuhiko Hashimura, Judy B de Haan, Karin Jandeleit-Dahm, Terri Allen, Lisa R. Tannock, John C Rutledge, Peter J. Little

Research output: Contribution to journalArticle

45 Scopus citations

Fingerprint Dive into the research topics of 'Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences